Literature DB >> 33923711

Antarctic Rahnella inusitata: A Producer of Cold-Stable β-Galactosidase Enzymes.

Kattia Núñez-Montero1,2, Rodrigo Salazar1,3, Andrés Santos1,3, Olman Gómez-Espinoza2,4, Scandar Farah1, Claudia Troncoso1,3, Catalina Hoffmann1, Damaris Melivilu1, Felipe Scott5, Leticia Barrientos Díaz1.   

Abstract

There has been a recent increase in the exploration of cold-active β-galactosidases, as it offers new alternatives for the dairy industry, mainly in response to the current needs of lactose-intolerant consumers. Since extremophilic microbial compounds might have unique physical and chemical properties, this research aimed to study the capacity of Antarctic bacterial strains to produce cold-active β-galactosidases. A screening revealed 81 out of 304 strains with β-galactosidase activity. The strain Se8.10.12 showed the highest enzymatic activity. Morphological, biochemical, and molecular characterization based on whole-genome sequencing confirmed it as the first Rahnella inusitata isolate from the Antarctic, which retained 41-62% of its β-galactosidase activity in the cold (4 °C-15 °C). Three β-galactosidases genes were found in the R. inusitata genome, which belong to the glycoside hydrolase families GH2 (LacZ and EbgA) and GH42 (BglY). Based on molecular docking, some of these enzymes exhibited higher lactose predicted affinity than the commercial control enzyme from Aspergillus oryzae. Hence, this work reports a new Rahnella inusitata strain from the Antarctic continent as a prominent cold-active β-galactosidase producer.

Entities:  

Keywords:  Antarctica; cold-adapted bacteria; extremozymes; lactose; β-galactosidase

Year:  2021        PMID: 33923711     DOI: 10.3390/ijms22084144

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  1 in total

Review 1.  Industrial applications of cold-adapted enzymes: challenges, innovations and future perspective.

Authors:  Anil Kumar; Srijana Mukhia; Rakshak Kumar
Journal:  3 Biotech       Date:  2021-09-06       Impact factor: 2.893

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.